Helius Medical Technologies
13F holders, Q3 2024 (September 30)14holders −1
1new positions
2sold out
$0.56avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Helius Medical Technologies in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Susquehanna International Group, LLP ($10K), Geode Capital Management, LLC ($10K) and Two Sigma Securities, LLC ($8K).
- Company
- Helius Medical Technologies
- CUSIP
- 42328V801
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $8K |
| Exits | 2 | $127K |
All 13F filers, Q2 2024 → Q3 2024: 30,568 shares bought and 132,124 shares sold, net −101,556 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Susquehanna International Group, LLP | 0.00% | Add +12.1% | 18,223 | $10K |
| Geode Capital Management, LLC | 0.00% | Add +21.5% | 17,751 | $10K |
| Two Sigma Securities, LLC | 0.00% | New | 14,242 | $8K |
| UBS Group AG | 0.00% | Add +723.9% | 12,762 | $7K |
| Vanguard Group Inc. | 0.00% | No change | 12,598 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.6% | 4,792 | $3K |
| CoreCap Advisors, LLC | 0.00% | No change | 200 | $112 |
| Osaic Holdings, Inc. | 0.00% | No change | 80 | $44 |
| American Capital Advisory, LLC | 0.00% | No change | 31 | $18 |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -13.5% | 32 | $18 |
| Bank of America Corp. | 0.00% | Add +45.0% | 29 | $16 |
| Morgan Stanley | 0.00% | No change | 4 | $2 |
| St Germain D J Co. Inc. | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is HELIUS MEDICAL TECHNOLOGIES's weight in each manager's 13F, not the share of Helius Medical Technologies the manager owns.